Evotec SE Q1 2024 Financial Results and Business Update
Ticker: EVOTF · Form: 6-K · Filed: May 22, 2024 · CIK: 1412558
| Field | Detail |
|---|---|
| Company | Evotec Se (EVOTF) |
| Form Type | 6-K |
| Filed Date | May 22, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, business-update, 6-K
TL;DR
Evotec SE dropped Q1 2024 results & biz updates on 5/22.
AI Summary
Evotec SE announced its first quarter 2024 financial results and business updates on May 22, 2024. The company is a foreign private issuer filing a Form 6-K report with the SEC.
Why It Matters
This filing provides investors with a timely update on Evotec's financial performance and strategic direction for the first quarter of 2024.
Risk Assessment
Risk Level: low — This is a routine financial disclosure filing (6-K) and does not contain new material risks.
Key Players & Entities
- Evotec SE (company) — Registrant
- May 22, 2024 (date) — Date of interim statement
- 2024 (date) — First quarter
FAQ
What type of report is Evotec SE filing?
Evotec SE is filing a Form 6-K report.
When did Evotec SE issue its interim statement?
Evotec SE issued its interim statement on May 22, 2024.
What period do the financial results and business updates cover?
The financial results and business updates cover the first quarter of 2024.
What is Evotec SE's principal executive office address?
Evotec SE's principal executive office is located at Essener Bogen 7, 22419 Hamburg, Germany.
Is Evotec SE required to file annual reports under Form 20-F or Form 40-F?
Evotec SE indicates it files annual reports under Form 20-F.
Filing Stats: 218 words · 1 min read · ~1 pages · Grade level 16.7 · Accepted 2024-05-22 06:00:16
Filing Documents
- tm2414848d1_6k.htm (6-K) — 10KB
- tm2414848d1_ex99-1.htm (EX-99.1) — 170KB
- tm2414848d1_ex99-1img003.jpg (GRAPHIC) — 99KB
- tm2414848d1_ex99-1sp2img001.jpg (GRAPHIC) — 4KB
- 0001104659-24-064017.txt ( ) — 323KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May, 2024 COMMISSION FILE NUMBER 001-34041 Evotec SE (Translation of registrant’s name into English) Essener Bogen 7 22419 Hamburg Germany Tel: +49 40 560810 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F: Form 20-F Form 40-F Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): On May 22, 2024, Evotec SE (the “Company”) issued an interim statement announcing the Company’s financial results and business updates for the first quarter 2024 attached hereto as Exhibit 99.1. SIGNATURE Pursuant to the requirements of s the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Evotec SE By: /s/ Laetitia Rouxel Name: Laetitia Rouxel Title: Chief Financial Officer Date: May 22, 2024 EXHIBIT INDEX Exhibit Description of Exhibit 99.1 Evotec SE interim statement Q1 2024 dated May 22, 2024